Patents Assigned to Loma Linda University
-
Patent number: 9370490Abstract: A method for producing triblock copolymer-coated metallic nanoparticle seeds which increases the size and shape homogeneity of the triblock copolymer-coated metallic nanoparticle seeds. A quantity of triblock copolymer-coated metallic nanoparticle seeds. A method for producing triblock copolymer-coated metallic nanoparticles which increases the size and shape homogeneity of the triblock copolymer-coated metallic nanoparticles. A quantity of triblock copolymer-coated metallic nanoparticles. A method for producing modified metallic nanoparticles which increases the size and shape homogeneity of the modified metallic nanoparticles. A quantity of modified metallic nanoparticles.Type: GrantFiled: February 28, 2013Date of Patent: June 21, 2016Assignee: Loma Linda UniversityInventors: Ralph S. Kurti, Jr., Christopher C. Perry, Theodore Sabir
-
Patent number: 9364205Abstract: A method and apparatus for closing a vascular wound includes an apparatus that can be threaded over a guidewire into place at or adjacent the wound. The apparatus includes a chamber that encloses a hemostatic material therein. When the apparatus is positioned adjacent the wound as desired, the hemostatic material is deployed from the chamber. Blood contacts the hemostatic material, and blood clotting preferably is facilitated by a hemostatic agent within the material. Thus, the vascular puncture wound is sealed by blood clot formation.Type: GrantFiled: September 6, 2011Date of Patent: June 14, 2016Assignee: Loma Linda University Medical CenterInventors: Yong Hua Zhu, Wolff M. Kirsch
-
Patent number: 9364578Abstract: This invention relates to deployable hemostatic materials comprising chitosan fibers. The hemostatic materials are suitable for use in sealing or controlling active bleeding from artery and vein lacerations and punctures, and for controlling oozing from tissue.Type: GrantFiled: February 28, 2014Date of Patent: June 14, 2016Assignee: Loma Linda University Medical CenterInventors: Yong Hua Zhu, Chang Zheng Yang, Wolff M. Kirsch
-
Patent number: 9358277Abstract: Methods for preventing, delaying the onset of, or treating rejection of an allograft using a DNA vaccine, where the vaccine can comprise a polynucleotide encoding a pro-apoptotic protein, like BAX and/or a polynucleotide encoding an autoantigen or donor antigen, like secreted glutamic acid decarboxylase 55. Administering one of the DNA vaccines to a transplant recipient, as described herein, can induce a donor specific tolerogenic response.Type: GrantFiled: July 6, 2012Date of Patent: June 7, 2016Assignee: Loma Linda UniversityInventors: Fengchun Li, Alan P. Escher
-
Patent number: 9351758Abstract: A needle access assembly and method for obtaining percutaneous needle access with little or no fluoroscopy. The method can include selecting a target for percutaneous access, directing a laser guide at a desired needle-insertion angle and in line with the selected target, aligning the needle access assembly with the laser, and inserting the needle into the target.Type: GrantFiled: April 3, 2015Date of Patent: May 31, 2016Assignee: FACULTY PHYSICIANS AND SURGEONS OF LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE: LOMA LINDA UNIVERSITYInventors: Dalton Duane Baldwin, Alexander Yeo, Jacob Martin
-
Publication number: 20160120944Abstract: Methods are disclosed herein for increasing bone mass and strength or bone fracture healing in a subject. The methods include administering to the subject a therapeutically effective amount of multipotent stem cells, wherein each multipotent stem cell is transformed with a recombinant nucleic acid molecule comprising a heterologous promoter operably linked to a nucleic acid encoding platelet derived growth factor (PDGF) B, and wherein the multipotent stem cells express a sufficient amount of PDGFB to increase bone mass and strength or bone fracture healing. A lentiviral vector also is disclosed that includes a phosphoglycerate kinase-1 (PGK) promoter operably linked to a nucleic acid encoding PDGFB.Type: ApplicationFiled: November 4, 2015Publication date: May 5, 2016Applicants: The United States Government as represented by the Department of Veterans Affairs, Loma Linda UniversityInventors: David Baylink, Kin-Hing William Lau, Wanqiu Chen, Xiao-Bing Zhang
-
Patent number: 9320505Abstract: A method and apparatus for closing a vascular wound includes a guidewire and/or other surgical implement extending from the wound. A hemostatic material is advanced over the surgical implement and into contact with an area of the blood vessel surrounding the wound. The surgical implement is removed. Blood soaks the hemostatic material, and blood clotting is facilitated by the hemostatic agent within the material. A sealing layer of adhesive can be applied to the hemostatic material, confining the blood flow to the material. The vascular puncture wound is sealed by natural blood clot formation.Type: GrantFiled: February 28, 2014Date of Patent: April 26, 2016Assignee: Loma Linda UniversityInventors: Yong Hua Zhu, Wolff M. Kirsch
-
Patent number: 9274067Abstract: Disclosed are systems, devices and methodologies related to calibration of an ion based imaging apparatus such as a proton computed tomography scanner. In some implementations, energy degrader plates having known water-equivalent thickness (WET) values can be introduced to an ion beam to introduce different energy degradation settings. Energy detector responses to individual ions subject to such energy degradation settings can be obtained. Such responses can be normalized and correlated to water-equivalent path lengths (WEPL) of the ions based on the known WET values. Such calibration utilizing degrader plates can be performed relatively quickly and can yield accurate WEPL values that facilitate estimation of, for example, a CT image based on relative stopping power of an object.Type: GrantFiled: September 22, 2014Date of Patent: March 1, 2016Assignee: LOMA LINDA UNIVERSITY MEDICAL CENTERInventors: Reinhard W. Schulte, R. Ford Hurley
-
Patent number: 9259357Abstract: A thin chitosan-based material can be used for biomedical applications. The chitosan has been treated in a nitrogen field by applying energy to ionize nitrogen in and around the chitosan material. A single or multiple such treatments may be employed. For example, the chitosan material may be irradiated under nitrogen using ?-irradiation, treated under a nitrogen plasma, or both. A thin chitosan material can be readily treated by surface modifying treatments such as irradiating under nitrogen using ?-irradiation, treating under a nitrogen plasma, or both.Type: GrantFiled: April 16, 2014Date of Patent: February 16, 2016Assignees: Loma Linda University, Loma Linda University Medical Center, North Carolina State UniversityInventors: Wolff M. Kirsch, Samuel M. Hudson, Andrew Crofton
-
Patent number: 9226988Abstract: A microfibrillar high molecular weight chitosan-based textile can be used as a hemostat. The chitosan has been treated in a nitrogen field by applying energy to ionize nitrogen in and around the chitosan textile. A single or multiple such treatments may be employed. For example, the chitosan textile may be irradiated under nitrogen using ?-irradiation, treated under a nitrogen plasma, or both.Type: GrantFiled: December 4, 2014Date of Patent: January 5, 2016Assignees: Loma Linda University Medical Center, North Carolina State UniversityInventors: Wolff M. Kirsch, Samuel Hudson
-
Patent number: 9220920Abstract: The therapeutic treatment of a patient using intensity-modulated proton therapy is described. In one example, a method of creating a proton treatment plan is presented that divides volumes of interest into sub-volumes, applies dose constraints to the sub-volumes, finds one or more feasible configurations of a proton therapy system, and selects a proton beam configuration that improves or optimizes one or more aspects of proton therapy. In some implementations, the method of dividing volumes into sub-volumes includes creating fractional sub-volumes based at least in part on proximity to a target volume boundary. In some implementations, the method of finding an improved or optimal proton beam configuration from a set of feasible configurations includes finding a minimum of a cost function that utilizes weighting factors associated with treatment sites.Type: GrantFiled: February 3, 2014Date of Patent: December 29, 2015Assignee: Loma Linda University Medical CenterInventors: Reinhard W. Schulte, Yair Censor
-
Patent number: 9213107Abstract: Disclosed are systems, devices and methodologies relating to an ion induced impact ionization detector and uses thereof. In certain implementations, the detector can include a dielectric layer having one or more wells. An anode layer defining apertures to accommodate the openings of the wells can be disposed on one side of the dielectric layer, and a cathode such as a solid resistive cathode can be disposed on the other side so as to provide an electric field in each of the wells. Various design parameters such as well dimensions and operating parameters such as pressure and high voltage are disclosed. In certain implementations, such an ion detector can be coupled to a low pressure gas volume to detect ionization products such as positive ions. Such a system can be configured to provide single ion counting capability. Various example applications where the ion detector can be implemented are also disclosed.Type: GrantFiled: March 10, 2014Date of Patent: December 15, 2015Assignee: Loma Linda University Medical CenterInventors: Vladimir Bashkirov, Reinhard W. Schulte
-
Patent number: 9207193Abstract: Disclosed are systems, devices and methodologies relating to proton computed tomography. In some implementations, detection of protons can yield track information before and after an object for each proton so as to allow determination of a likely path of each proton within the object. Further, measurement of energy loss experienced by each proton allows determination that a given likely path results in a given energy loss. A collection of such data allows characterization of the object. Such a characterization can include an image map of relative stopping power of the object. Various reconstruction methodologies for obtaining such an image can include superiorization of a merit function such as total variation. Various forms of total variation superiorization methodology can yield excellent results with reduced computing time. In some implementations, such a methodology can result in high quality proton CT images using relatively low dose of protons.Type: GrantFiled: February 11, 2011Date of Patent: December 8, 2015Assignees: LOMA LINDA UNIVERSITY MEDICAL CENTER, UNIVERSITY OF HAIFA, UNIVERSITY OF WOLLONGONGInventors: Yair Censor, Scott N. Penfold, Reinhard W. Schulte
-
Patent number: 9179987Abstract: A method for reducing angulation error during the placement of dental implants or other dental procedures. Two or more sensors are used to monitor realtime orientation of a dental handpiece. One or more signal emitters are used in order to notify the user that a first orientation of the dental handpiece has been identified and recorded. One or more signal emitters are used to notify the user that the dental handpiece has been repositioned into a second orientation having a predetermined spatial relationship to the first orientation.Type: GrantFiled: January 17, 2013Date of Patent: November 10, 2015Assignee: Loma Linda UniversityInventor: Brian J. Goodacre
-
Patent number: 9179902Abstract: A method and apparatus for closing a vascular wound includes an apparatus that can be threaded over a guidewire into place at or adjacent the wound. The apparatus includes a chamber that encloses a hemostatic material therein. When the apparatus is positioned adjacent the wound as desired, the hemostatic material is deployed from the chamber. A blocking member distal of the hemostatic material functions as a barrier to prevent the hemostatic material from entering the wound. Blood contacts the hemostatic material, and blood clotting preferably is facilitated by a hemostatic agent within the material. Thus, the vascular puncture wound is sealed by blood clot formation.Type: GrantFiled: October 31, 2013Date of Patent: November 10, 2015Assignee: Loma Linda University Medical CenterInventors: Yong Hua Zhu, Wolff M. Kirsch
-
Patent number: 9173553Abstract: The present disclosure relates to systems and methods for controlling pressure during percutaneous and endoscopic surgeries, including percutaneous renal procedures, endoscopic uterine procedures, transurethral endoscopic procedures for the bladder or prostate, or any percutaneous or endoscopic procedure. The system can include a sheath and/or endoscope each having an inflow port providing access to an inflow channel extending from the inflow port to a distal portion of the sheath, and an outflow port providing access to an outflow channel extending from the outflow port to the distal portion of the sheath. The sheath can also include a pressure sensor configured to generate a pressure measurement, and an electronic processor configured to control fluid through at least one of the inflow port and the outflow port based on the pressure measurement.Type: GrantFiled: October 30, 2014Date of Patent: November 3, 2015Assignee: FACULTY PHYSICIANS AND SURGEONS OF LOMA LINDA UNIVERSITY SCHOOL OF MEDICINEInventor: Dalton Duane Baldwin
-
Patent number: 9101731Abstract: A method and apparatus for closing a vascular wound includes a guidewire and/or other surgical implement extending from the wound. A hemostatic material is advanced over the surgical implement and into contact with an area of the blood vessel surrounding the wound. The surgical implement is removed. Blood soaks the hemostatic material, and blood clotting is facilitated by the hemostatic agent within the material. A sealing layer of adhesive can be applied to the hemostatic material, confining the blood flow to the material. Thus, the vascular puncture wound is sealed by natural blood clot formation.Type: GrantFiled: June 20, 2013Date of Patent: August 11, 2015Assignee: Loma Linda University Medical CenterInventors: Yong Hua Zhu, Wolff M. Kirsch
-
Patent number: 9095361Abstract: A needle access assembly and method for obtaining percutaneous needle access with little or no fluoroscopy. The method can include selecting a target for percutaneous access, directing a laser guide at a desired needle-insertion angle and in line with the selected target, aligning the needle access assembly with the laser, and inserting the needle into the target.Type: GrantFiled: June 3, 2014Date of Patent: August 4, 2015Assignee: FACULTY PHYSICIANS AND SURGEONS OF LOMA LINDA UNIVERSITY SCHOOL OF MEDICINEInventor: Dalton Duane Baldwin
-
Patent number: 9084886Abstract: According to the improved systems and methods described herein, a patient may be immobilized so that one or both breasts are returned to a known position. Additionally, the improved systems and methods reduce respiratory movement of the breasts. Thus, the immobilization devices and techniques described herein provide accurate and reproducible breast positioning while simultaneously reducing respiratory motion.Type: GrantFiled: August 30, 2013Date of Patent: July 21, 2015Assignee: Loma Linda University Medical CenterInventor: David A. Bush
-
Patent number: 9084887Abstract: Disclosed are systems and methods for characterizing interactions or proton beams in tissues. In certain embodiments, charged particles emitted during passage of protons, such as those used for therapeutic and/or imaging purposes, can be detected at relatively large angles. In situations where beam intensity is relatively low, such as in certain imaging applications, characterization of the proton beam with charged particles can provide sufficient statistics for meaningful results while avoiding the beam itself. In situations where beam intensity is relatively high, such as in certain therapeutic applications, characterization of the proton beam with scattered primary protons and secondary protons can provide information such as differences in densities encountered by the beam as it traverses the tissue and dose deposited along the beam path. In certain situations, such beam characterizations can facilitate more accurate planning and monitoring of proton-based therapy.Type: GrantFiled: January 20, 2014Date of Patent: July 21, 2015Assignee: Loma Linda University Medical CenterInventors: Reinhard W. Schulte, Vladimir A. Bashkirov